Reliq Health Technologies Inc. (RQHTF) Announces New Contract with Texas Based Chronic Care Management Provider

“We are excited to be working with B Golden Care Services,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.  “Reliq’s iUGO Care platform will help B Golden track and manage their patients and enable automated claims submissions to Medicare and Medicaid. iUGO Care helps healthcare organizations like B Golden provide high quality care more efficiently with tools that support patient triaging, scheduling, caregiver workflows and billing. Our platform allows healthcare providers to proactively manage complex chronic care patients in the lower cost community setting, reducing the need for costly and disruptive acute interventions such as hospital stays, long term care admissions and ER visits.”

“Our mandate at B Golden is to support patients with complex chronic conditions who are aging in place,” said Mr. Joseph Estapa, President and CEO of B Golden Care Services.  “Studies consistently show that providing patients with medication reminders, coaching and education in the home setting drives patient engagement and improves health outcomes.  We are passionate about improving access to care for patients in our community and helping people stay healthy and at home as they age.”

B Golden Care Services, LLC is a new and growing chronic care management agency in Southern Texas.  The company provides services to patients in the home setting, supporting patients aging in place, improving medication adherence and empowering patients to proactively manage their own health.

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare.  The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

For further information contact:

Renmark Financial Communications Inc. 
Laura Welsh: lwelsh@renmarkfinancial.com
Tel: (416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com

or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.